|Articles|November 1, 2018
- Pharmaceutical Executive-11-01-2018
- Volume 38
- Issue 11
Pharmaceutical Executive, November 2018 Issue (PDF)
Click the title above to open the Pharmaceutical November 2018 issue in an interactive PDF format.
Advertisement
Articles in this issue
over 7 years ago
Pharm Exec's 2019 Pipeline Reportover 7 years ago
High-Risk Marketing Violations Draw Scrutinyover 7 years ago
Biopharma Business Checkover 7 years ago
Patent Protection for Cannabis?over 7 years ago
Steadying the Path of Good Scienceover 7 years ago
Southeast Biotech: Rising Tall in the Valleyover 7 years ago
Fighting for a Streamlined European HTA Schemeover 7 years ago
Stunted Innovation in Drug Development?over 7 years ago
Country Report: AlgeriaNewsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
TrumpRx Selling Medicines at Higher Prices Than Other Countries: Report
2
What Pharma Marketers Need to Know About Recent Gartner Predictions About AI and What It Means to Them
3
Pharmaceutical Executive Daily: Analysis on TrumpRx List Pricing
4
What Are the ‘Last Mile Issues’ Impacting Pharma?
5